Daniel Karlin
Chief Medical Officer at Definium Therapeutics Inc.
Sits on 1 board. Last updated September 30, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 week
- Director since
- 2026
1 week of board service in total across 1 board, counting each seat separately. Longest: Definium Therapeutics Inc., 1 week.
Definium Therapeutics Inc.
Director · Chief Medical Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 2026 | Definium Therapeutics Inc. | Open-market sale | −10,853 | $36.57 | $396,894 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.